stillwork
Peptide

CJC-1295 No DAC

Growth hormone rhythm amplifier

A modified growth hormone releasing hormone (GHRH) analog that extends GH release duration. The no-DAC version provides pulsatile release more similar to natural patterns.

Mechanisms

  • GHRH receptor agonism
  • GH pulse amplification
  • IGF-1 stimulation

Dosing

Typical dose

100–200mcg

Timing

Combine with a GHRP like Ipamorelin for optimal results. Evening dosing preferred.

Synergies

Tesamorelin

CJC-1295 and Tesamorelin both act on GHRH pathways for synergistic GH release

Moderate
Ipamorelin

Ipamorelin and CJC-1295 together maximize GH pulse amplitude and duration

Strong